Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Dasatinib in imatinib-resistant or -intolerant chronic-phase, chronic myeloid leukemia patients: 7-year follow-up of study CA180-034.

Shah NP, Rousselot P, Schiffer C, Rea D, Cortes JE, Milone J, Mohamed H, Healey D, Kantarjian H, Hochhaus A, Saglio G.

Am J Hematol. 2016 Sep;91(9):869-74. doi: 10.1002/ajh.24423. Epub 2016 Jun 20.

2.

Allogeneic hematopoietic stem cell transplantation in the elderly. Predicting the risk for non relapse mortality.

Berro M, Basquiera AL, Rivas MM, Foncuberta MC, Burgos R, Jaimovich G, Milovic V, Martínez Rolón J, Remaggi G, Alberbide J, Milone J, Prates V, Rizzi ML, Jarchum G, García JJ, Kusminsky G.

Medicina (B Aires). 2015;75(4):201-6.

3.

Allogeneic hematopoietic stem cell transplantation in adults with myelodysplastic syndrome: Experience of the Argentinean Group of Bone Marrow Transplantation (GATMO).

Basquiera AL, Rivas MM, Remaggi G, Klein G, Milovic V, Foncuberta MC, Saba S, Milone JH, Arbelbide J, Jaimovich G, Rolón JM, Kusminsky G, García JJ, Prates MV.

Hematology. 2016 Apr;21(3):162-9. doi: 10.1179/1607845415Y.0000000028. Epub 2015 Jul 6.

PMID:
26147089
4.

Continuing to strengthen FDA's science approach to emerging technologies.

Anatol R, Bauer S, Epstein S, Filice R, Lauritsen K, Lee MH, Mansfield E, McMurry-Heath M, Milone J, Peña C, Pollack S, Zineh I.

Nanomedicine. 2013 Jul;9(5):594-9. doi: 10.1016/j.nano.2013.04.005. Epub 2013 May 18.

PMID:
23692697
5.

The impact of supervision on internal medicine residents' attitudes and management of depression in primary care: a pilot study.

Milone JM, Gottumukkala A, Ward CP, York KM.

Acad Psychiatry. 2013 Mar 1;37(2):94-7. doi: 10.1176/appi.ap.11090156.

PMID:
23475236
6.

T-cell lymphomas in South america and europe.

Bellei M, Chiattone CS, Luminari S, Pesce EA, Cabrera ME, de Souza CA, Gabús R, Zoppegno L, Zoppegno L, Milone J, Pavlovsky A, Connors JM, Foss FM, Horwitz SM, Liang R, Montoto S, Pileri SA, Polliack A, Vose JM, Zinzani PL, Zucca E, Federico M.

Rev Bras Hematol Hemoter. 2012;34(1):42-7. doi: 10.5581/1516-8484.20120013.

7.

Shedding light on women's response to "Twilight".

Milone J, Gabbard GO.

Acad Psychiatry. 2011 Nov 1;35(6):411-4. doi: 10.1176/appi.ap.35.6.411. No abstract available.

PMID:
22193743
8.

Dasatinib or imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: 2-year follow-up from a randomized phase 3 trial (DASISION).

Kantarjian HM, Shah NP, Cortes JE, Baccarani M, Agarwal MB, Undurraga MS, Wang J, Ipiña JJ, Kim DW, Ogura M, Pavlovsky C, Junghanss C, Milone JH, Nicolini FE, Robak T, Van Droogenbroeck J, Vellenga E, Bradley-Garelik MB, Zhu C, Hochhaus A.

Blood. 2012 Feb 2;119(5):1123-9. doi: 10.1182/blood-2011-08-376087. Epub 2011 Dec 9.

9.

PolyA-specific ribonuclease (PARN-1) function in stage-specific mRNA turnover in Trypanosoma brucei.

Utter CJ, Garcia SA, Milone J, Bellofatto V.

Eukaryot Cell. 2011 Sep;10(9):1230-40. doi: 10.1128/EC.05097-11. Epub 2011 Jul 8.

10.

Clinical outcome of chronic myeloid leukemia imatinib-resistant patients: do BCR-ABL kinase domain mutations affect patient survival? First multicenter Argentinean study.

Bengió RM, Riva ME, Moiraghi B, Lanari E, Milone J, Ventriglia V, Bullorsky E, Tezanos Pinto Md, Murro H, Bianchini M, Larripa I.

Leuk Lymphoma. 2011 Sep;52(9):1720-6. doi: 10.3109/10428194.2011.578310. Epub 2011 Jun 12.

PMID:
21663510
11.

Molecular monitoring of imatinib in chronic myeloid leukemia patients in complete cytogenetic remission: does achievement of a stable major molecular response at any time point identify a privileged group of patients? A multicenter experience in Argentina and Uruguay.

Pavlovsky C, Giere I, Moiraghi B, Pavlovsky MA, Aranguren PN, García J, Fernandez I, Bengió R, Milone J, Labanca V, Uriarte R, Lombardi V, Reinoso FG, Magariños AE, Martinez L, Murro H, Lastiri F, Pavlovsky S.

Clin Lymphoma Myeloma Leuk. 2011 Jun;11(3):280-5. doi: 10.1016/j.clml.2011.03.016. Epub 2011 Apr 20.

PMID:
21658656
12.

The effect of lecture and a standardized patient encounter on medical student rape myth acceptance and attitudes toward screening patients for a history of sexual assault.

Milone JM, Burg MA, Duerson MC, Hagen MG, Pauly RR.

Teach Learn Med. 2010 Jan;22(1):37-44. doi: 10.1080/10401330903446321.

PMID:
20391282
13.

Treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia.

Milone JH, Enrico A.

Leuk Lymphoma. 2009 Dec;50 Suppl 2:9-15. doi: 10.3109/10428190903370395. Review.

PMID:
20017606
14.

Intermittent target inhibition with dasatinib 100 mg once daily preserves efficacy and improves tolerability in imatinib-resistant and -intolerant chronic-phase chronic myeloid leukemia.

Shah NP, Kantarjian HM, Kim DW, Réa D, Dorlhiac-Llacer PE, Milone JH, Vela-Ojeda J, Silver RT, Khoury HJ, Charbonnier A, Khoroshko N, Paquette RL, Deininger M, Collins RH, Otero I, Hughes T, Bleickardt E, Strauss L, Francis S, Hochhaus A.

J Clin Oncol. 2008 Jul 1;26(19):3204-12. doi: 10.1200/JCO.2007.14.9260. Epub 2008 Jun 9.

PMID:
18541900
15.
16.

Assessing messenger RNA decapping in cellular extracts.

Bergman N, Milone J, Bates EJ, Opyrchal M, Bellofatto V, Wilusz J.

Methods Mol Biol. 2004;257:181-92.

PMID:
14770006
17.

Response to single-agent thalidomide and eligibility to undergo autotransplant for patients with multiple myeloma refractory to VAD.

Milone JH, Prates V, Bordone J, Napal J, Garcia C.

Bone Marrow Transplant. 2003 Aug;32(3):343. No abstract available.

PMID:
12858210
18.

Autologous stem cell transplantation for patients with chronic myeloid leukemia. The Argentine Group of Bone Marrow Transplantation (GATMO) experience.

Koziner B, Dengra C, Lucero G, Klein G, Cánepa C, Milovic V, Milone G, Robinson A, Cerutti I, Saporito G, Kusminsky G, Milone J, Bordone J, Lastiri F; Argentine Group of Bone Marrow Transplantation.

Cancer. 2002 Dec 1;95(11):2339-45.

19.
20.

Cell processing practices in Argentina: report of a multicenter survey.

Bertinetti C, Milone G, Kohan A, Saporito G, Robinson A, García JJ, Milone J, Cerutti I, Feldman L, Jarchum G, Bordone J, Koziner B.

Cytotherapy. 2001;3(2):127-33. No abstract available.

PMID:
12028835
21.

[Umbilical cord hematopoietic progenitor cells bank].

Morales VH, Milone J, Etchegoyen O, Bordone J, Uranga A.

Medicina (B Aires). 2001;61(6):843-8. Spanish.

PMID:
11808425
22.

Response

Milone J, Napal J, Etchegoyen O, Morales V V.

Bone Marrow Transplant. 2000 Jun;25(11):1218. No abstract available.

23.

The first report of familial adult T-cell leukemia/lymphoma in Argentina.

Prates V, Cobos M, Bouzas B, Napal J, Bordone J, Milone J.

Leuk Lymphoma. 2000 Mar;37(1-2):225-7.

PMID:
10721791
24.

Graft versus host disease in autologous stem cell transplantation.

Marin GH, Porto A, Prates V, Napal J, Etchegogen O, Rubens L, Bordone J, Castelletto R, Buschiazzo H, Morales V, Milone J.

J Exp Clin Cancer Res. 1999 Jun;18(2):201-8.

PMID:
10464707
25.

[Bone marrow transplantation in chronic myeloid leukemia].

Milone JH, Bordone J, Etchegoyen O, Napal J, Prates MV, Morales VH.

Medicina (B Aires). 1999;59(1):1-10. Spanish.

PMID:
10349111
26.

Complete response in severe thrombotic microangiopathy post bone marrow transplantation (BMT-TM) after multiple plasmaphereses.

Milone J, Napal J, Bordone J, Etchegoyen O, Morales V.

Bone Marrow Transplant. 1998 Nov;22(10):1019-21.

27.

Multivariate analyses of prognostic factors associated with hematopoietic recovery in autograft patients with different sources of progenitor cells. A GATMO experience. Argintine Group of Bone Marrow Transplant.

Pavlovsky S, Koziner B, Milone G, Lastiri F, Bayo R, Fernández I, Dengra C, Martinez Rolón J, Feldman L, Kusminsky G, Corrado C, Bullorsky E, Milone J, Garcia JJ, Cerutti I, Saporito G, Robinson A, Canepa C.

Ann Oncol. 1996 Sep;7(7):719-24.

PMID:
8905030
28.

[Adult HTLV-I positive leukemia-lymphoma in Argentina].

Gioseffi ON, Nucifora E, Fantl D, Dufour C, Milone J, Di Paolo H.

Sangre (Barc). 1995 Oct;40(5):421-4. Spanish.

PMID:
8553178
29.

Vindesine, prednisone, and daunomycin in acute lymphoblastic leukemia in relapse.

Garay G, Milone J, Dibar E, Pavlovsky S, Kvicala R, Sackmann Muriel F, Montres Varela D, Eppinger-Helft M.

Cancer Chemother Pharmacol. 1983;10(3):224-6.

PMID:
6345018

Supplemental Content

Loading ...
Support Center